Evidence map›Paper›PMID 41594744›Full record

ArticleBrain sciences2025

Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study.

Farid Juya, Kristin Klemmetsby Solli, Ann-Christin Sannes, Bente Weimand, Johannes Gjerstad, Lars Tanum, Jon Mordal

Abstract read
In one paragraph

Article in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Farid JuyaDivision of Mental Health and Addiction, Vestfold Hospital Trust, 3103 Tønsberg, Norway.ORCID 0009-0008-6522-0473
Kristin Klemmetsby SolliDivision of Mental Health and Addiction, Vestfold Hospital Trust, 3103 Tønsberg, Norway.ORCID 0000-0003-4622-2947
Ann-Christin SannesDepartment of R&D in Mental Health, Akershus University Hospital, 1478 Lørenskog, Norway.ORCID 0000-0002-3918-8149
Bente WeimandDepartment of R&D in Mental Health, Akershus University Hospital, 1478 Lørenskog, Norway.ORCID 0000-0003-1800-7318
Johannes GjerstadDepartment of R&D in Mental Health, Akershus University Hospital, 1478 Lørenskog, Norway.ORCID 0000-0002-1292-3465
Lars TanumDepartment of R&D in Mental Health, Akershus University Hospital, 1478 Lørenskog, Norway.ORCID 0000-0003-4001-6325
Jon MordalDivision of Mental Health and Addiction, Vestfold Hospital Trust, 3103 Tønsberg, Norway.ORCID 0009-0006-9868-2450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antagonist treatmentCOMTgenetic polymorphismsopioid use disorderOPRM1treatment outcomes

Identifiers

PMID41594744
PMCPMC12838570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.